MedTrace Logo

CVCs Versus Midline Catheters

NCT06884176 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-04-02

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if midline catheters can reduce adverse patient outcomes in adult patients requiring a single vasopressor. The main questions the study aims to answer are:

* Do midline catheters reduce the rates of catheter-related bloodstream infections as compared to central venous catheters?
* Do midline catheters reduce the rates of deep venous thrombosis as compared to central venous catheters? Researchers will compare midline catheters to central venous catheters to see if there is a reduction in these events.

Participants will be randomized to the midline catheter group or the central venous catheter group. The catheters will be part of standard of care for vasopressor therapy. The participants will be followed for 30 days.

Conditions

  • Central Venous Catheter
  • Midline Catheter
  • Complication of Catheter

Interventions

DEVICE

Ultrasound Guided Central Venous Catheter

Patients randomized to this arm will receive an ultrasound guided central venous catheter. The catheter is 20cm in length.

DEVICE

Ultrasound Guided Midline Catheter

Patients randomized to this arm will receive an ultrasound guided midline catheter. The catheter is 8-10cm in length.

Sponsors & Collaborators

  • Jacobi Medical Center

    collaborator OTHER

  • Albert Einstein College of Medicine

    lead OTHER

Principal Investigators

  • Sandeep Dhillon, MD · Jacobi Medical Center, Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06884176 on ClinicalTrials.gov